Obesity and heart failure prognosis: paradox or reverse epidemiology?
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
This editorial refers to ‘Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function’† by F. Gustafsson et al., on page 58 Obesity is a problem reaching epidemic proportions in westernized society and is a major cause of preventable death.1 Obesity has many adverse effects on coronary artery disease (CAD) risk factors and is probably an independent risk factor for CAD events. Epidemiological studies have clearly shown a strong relationship between obesity and increased risk of cardiovascular disease and mortality in the general population,1,2 although in some of these studies a ‘J-shaped’ or ‘U-shaped’ curve has been present, meaning that those individuals with low body mass index (BMI) also have increased mortality. Obesity is also known to exert numerous adverse effects on cardiac function. In early obesity, an expanded intravascular volume results in an increase in cardiopulmonary volume or increased pre-load.1,3 Over time these changes lead to an increased prevalence of eccentric left ventricular hypertrophy and the propensity for more complex ventricular dysrhythmias; we and others have noted these early abnormalities as well as improvements in both diastolic and systolic ventricular function following marked, purposeful weight reduction.1 Finding the relationship between obesity and heart failure (HF), however, has been complex. A recent epidemiological study from the Framingham Heart Study clearly indicates that obesity and being overweight are potent predictors of subsequent clinical HF.4 Although obesity causes abnormalities in diastolic and systolic function and predisposes to clinical HF, obese patients with HF paradoxically seem to have a more favourable clinical prognosis.1–3,5,6 Kalantar-Zadeh et al.2 have recently reviewed six studies demonstrating that, among patients with HF, obesity appears to be associated with a better overall clinical prognosis and patients with more severe HF tend to have lower BMI than do age- and gender-matched control subjects. Among the studies reviewed, Horwich et al.5 studied 1203 individuals with mostly class IV HF, and found that a higher BMI was associated with a better survival rate (Figure 1) and, in multivariate analysis, there was an inverse association between BMI and mortality. We recently studied 209 patients with mostly class II and III HF and a mean ejection fraction of only 23%; we found that higher BMI and higher percentage body fat were associated with better event-free survival during a 2 year follow-up.6 In fact, in multivariate analysis, a higher percentage body fat was the strongest independent predictor of event-free survival. We have described this as an ‘obesity paradox’ whereas others have described the relationship between some of the cardiovascular risk factors and chronic HF prognosis as ‘reverse epidemiology’.2 Importantly, only limited information is available on whether this relationship is causal or merely an association. It is postulated that lower body weight may be associated with a heightened catabolic state, which is associated with high levels of tumour necrosis factor and other cytokines and increased cortisol/dihydroepiandrosterone balance.6 Clearly, in advanced HF, cachexia and wasting appear to be independent predictors of increased mortality.7 However, in our cohort of patients with HF in the lowest quintile of body composition parameters, the BMI and percentage body fat values were at levels generally considered to be ‘healthy’ and certainly not at levels consistent with a cachetic state. In the current issue of the European Heart Journal, Gustafsson et al.8 present data which further suggest a protective influence of increasing BMI on subsequent mortality in 4700 patients hospitalized with HF. Moreover, they demonstrated the impact of chronic obstructive lung disease in these patients, and that obesity seems to be particularly protective in HF patients with more preserved systolic function. Unlike most of the other studies in the literature, however, they did not find a better clinical prognosis in obese patients with more systolic dysfunction, although they did note the considerable differences in their study population compared with the others in the literature, particularly the higher age and their acute hospitalization status. The strength of their study is the very large sample size and the hard endpoint (total mortality). A weakness is that their data may be confounded by presentation with an acutely decompensated HF event requiring hospitalization. There could also be an interaction of co-morbidities in that the patients who died were older and had more renal dysfunction, atrial fibrillation, smoking, and obstructive lung disease, and lower use of angiotensin converting enzyme inhibitors, and many of these factors, including lung disease, are known to be associated with a poor HF prognosis.9 In addition, medications were not accounted
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 4×
“In the current issue of the European Heart Journal, Gustafsson et al.8 present data which further suggest a protective influence of increasing BMI on subsequent mortality in 4700 patients hospitalized with HF.”
BackgroundInfluentialThe relationship between obesity and mortality in patients with heart failure
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Woo, M. A., & Tillisch, J. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01448-6 · Cited by 867 · cited 2×
“Among the studies reviewed, Horwich et al.(5) studied 1203 individuals with mostly class IV HF, and found that a higher BMI was associated with a better survival rate (Figure 1 ) and, in multivariate analysis, there was an inverse association between BMI and mortality.”
BackgroundObesity and suppressed B-type natriuretic peptide levels in heart failure
Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.066 · Cited by 534 · cited 6×
“In the current issue of the European Heart Journal, Gustafsson et al.8 present data which further suggest a protective influence of increasing BMI on subsequent mortality in 4700 patients hospitalized with HF.”
BackgroundSelf-citationLavie (2003) · doi:10.1016/s0735-1097(03)00784-8 · Cited by 160
Cited by
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
Self-citationObesity and cardiovascular disease: revisiting an old relationship
Koliaki, C., Liatis, S., & Kokkinos, A. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.011 · Cited by 719
Kenchaiah, S., Pocock, S. J., Wang, D., Finn, P. V., Zornoff, L. A. M., Skali, H., Pfeffer, M. A., Yusuf, S., Swedberg, K., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.679779 · Cited by 413
Obesity and Heart Failure: Focus on the Obesity Paradox
Carbone, S., Lavie, C. J., & Arena, R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.11.001 · Cited by 287
Self-citationUpdate on Obesity and Obesity Paradox in Heart Failure
Lavie, C. J., Sharma, A., Alpert, M. A., De Schutter, A., Lopez-Jimenez, F., Milani, R. V., & Ventura, H. O. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.12.003 · Cited by 267
Self-citation
Metadata
- Authors
- Lavie, C. J., Mehra, M. R., & Milani, R. V.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-30
- Volume
- 26
- Issue
- 1
- Pages
- 5-7
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2155483408
- Cited by
- 128
- References
- 4
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity and heart failure prognosis: paradox or reverse epidemiology? https://app.cochat.ai/papers/10.1093/eurheartj/ehi055
- The paper
- Lavie, C. J., Mehra, M. R., & Milani, R. V. (2005). Obesity and heart failure prognosis: paradox or reverse epidemiology? European Heart Journal. https://doi.org/10.1093/eurheartj/ehi055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.